Published by Jessica Weisman-Pitts
Posted on March 28, 2025
Fear of Evolving COVID Variants and Ability to Detect Multiple Diseases Increasing Use of Polymerase Chain Reaction Technologies: Fact.MR Analysis
As per this updated industry report by Fact.MR, a market research and competitive intelligence provider, the global Polymerase Chain Reaction Market is estimated at a value of US$ 6.2 billion in 2024 and is projected to increase further at a CAGR of 10% through 2034.
Polymerase chain reaction (PCR) technology has been gaining widespread importance in genetic testing. Ongoing advancements are set to introduce cutting-edge PCR products over the coming years. Introduction of molecular and point-of-care (POC) diagnosis is also expected to complement polymerase chain reaction market growth. Rising prevalence of infectious diseases and increasing demand for sophisticated diagnostic methods are increasing the popularity of real-time polymerase chain reaction technologies
Cases of chronic and genetic disorders such as Turner syndrome, Alzheimer's, and Parkinson's disease are increasing at a high pace across the world. Healthcare experts are demanding advanced molecular diagnostic tools for accurate diagnoses. Through the use of these tools, doctors can make quick and effective treatment decisions. Altering lifestyles, stress, improper diet, and high consumption of alcoholic products are increasing the cases of cancer. Leading producers are analyzing all these aspects and are focused on introducing rapid medical diagnosis solutions such as RT-PCR to detect disease quickly and offer proper care.
Receive a Tailored Analysis for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=4861
Polymerase Chain Reaction Industry News & Trends:
South Korean PCR molecular diagnostics manufacturer Seegene Inc. announced in January 2024 that it was partnering with Microsoft on technology for its SG OneSystemTM business model.
The Applied Biosystem QuantStudio Absolute Q-Digital PCR System, the first fully integrated digital PCR (dPCR) system, was introduced in 2021 by Thermo Fisher Scientific, a US-based company that supplies scientific equipment, reagents, and consumables. It is intended to deliver extremely accurate and consistent results in genetic analysis and research in less than 90 minutes.
Cases of corona, due to its evolving variants, are still prevalent across the world. This factor is also driving the use of qPCR technologies for rapid testing.
Key Takeaways from Polymerase Chain Reaction Industry Study
“Increasing demand for prenatal genetic testing procedures is set to boost the adoption of qPCR and dPCR technologies over the coming years,” says Fact.MR analyst.
Get a Custom Analysis for Targeted Research Solutions:https://www.factmr.com/connectus/sample?flag=S&rep_id=4861
Competitive Analysis:
The polymerase chain reaction market is highly competitive due to the high presence of established companies. Prime focus point of new as well as prominent companies is innovation to increase their market reach and share. For this, they are adopting various strategies such as integration of digital technologies, high investments in research and development activities, collaborations with research organizations, partnerships with other players, and fundraising.
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global polymerase chain reaction market, presenting historical demand data (2019 to 2023) and forecast statistics for the period (2024 to 2034).
The study divulges essential insights on the market based on product (PCR instruments, standard PCR systems, RT PCR systems, digital PCR systems, PCR reagents, PCR consumables) and end user (pharmaceutical & biotechnology industries, clinical diagnostics labs & hospitals, academic & research organizations), across seven major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and MEA).
Explore More Related Studies Published by Fact.MR Research:
Bone And Joint Health Supplement Market is expanding from an estimated $34.89 billion in 2024 to a colossal $71.91 billion by 2034, fueled by a CAGR of 7.5%.
Nutraceutical Supplement Market is expanding from an estimated $87.41 billion in 2024 to a colossal $201.75 billion by 2033, fueled by a CAGR of 5.9%.
Liquid Dietary Supplement Market size is calculated at US$ 49.4 Bn for 2024 & is forecasted to grow at US$ 120 Bn, expanding at a stellar 9.2% CAGR by 2034
The Demand For Mineral Supplements is expanding from an estimated $19.21 Bn in 2024 to a colossal $29.56 Bn by 2034, fueled by an impressive CAGR of 4.4.
The Sports Supplement Market is expanding from an estimated $8.92 Bn in 2024 to a colossal $27.89 Bn by 2034, fueled by an impressive CAGR of 12.1%.
The Vitamin Supplement Market is expanding from an estimated $56 billion in 2024 to a colossal $115.5 billion by 2034, fueled by a CAGR of 7.5%.
Marine Supplements Market is valued about US$ 6,635.4 million in 2023. The United States is expected to have a market share of 27.6% by the end of 2033.
Natural Health Supplement Market is expanding from an estimated $58.27 Bn in 2024 to a colossal $121.76 Bn by 2034, fueled by 7.6% CAGR.
Explore more articles in the Research Reports category
